LITESPARK-022 Update: Adjuvant Belzutifan + Pembrolizumab in High-Risk Clear Cell Renal Cell Carcinoma

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

MSK Awards and Appointments January 2026

Guru Sonpavde: Early Success With EV and FGFR Inhibitor in Bladder Cancer Patients

15 Posts Not To Miss From ASCO GU 2026

Oncology News, Insights, Stories by OncoDaily

60 questions about SCLC with Dr. Greg Kalemkerian Part 2
Dialogues

60 questions about SCLC with Dr. Greg Kalemkerian Part 2

Roquefort Therapeutics Acquires Global Rights to TACC3 Inhibitor AO-252 in £31.9M Deal, Pivoting to Clinical-Stage Oncology
Oncology Tech

Roquefort Therapeutics Acquires Global Rights to TACC3 Inhibitor AO-252 in £31.9M Deal, Pivoting to Clinical-Stage Oncology

ESGO
Not To Miss

15 Posts Not To Miss from ESGO 2026

Why Chemotherapy Stops Working: The Science of Cancer Drug Resistance

Do Electric Cars Cause Cancer? The Truth Behind the Myths and Facts About EV EMFs

What It Takes to be a Healthcare Leader? - Humaid Al-Shamsi

KEYNOTE-585: Early Pathologic Endpoints and Survival with Perioperative Pembrolizumab Plus Chemotherapy

Chiara Gasparotto: Closing a Chapter at ESTRO with Gratitude

Ghassan Abou-Alfa: Honored to Contribute to OncoDaily Teaching Effort on Biliary Cancers

Patrick Soon-Shiong: Discussing IL-15 Cancer Research with NIH and NCI Leaders

Cervical Cancer 2026
OncoThon 2026
Advances in The Immunotherapy of Cold Tumors
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Myeloma Paper of the Day

Myeloma Paper of the Day, March 3rd, Suggested by Robert Orlowski

Patrick Soon-Shiong: My Talk at 55th Anniversary of President Nixon’s War on Cancer

Bente Mikkelsen Supports Global Action for Children With Cancer

Hannah Wardill: Why Some Patients Develop Chemobrain and Others Don’t?

Rasha Aboelhassan Spotlights ASCO 2026 SEP Digital Cover Art Competition

Dr. Andrea Cercek and Dr. Luis Diaz Jr. Accepted into STAT Madness Round 1 - MSK

Maria Maddalena Laterza: Immunotherapy in Hepatobiliary Cancers: A True Paradigm Shift

FDA Approvals
FDA approval BRAFTOVI

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation in FGF19-Overexpressing Advanced HCC

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

56th Annual Radiation Oncology Research Seminar

UF Health Cancer Institute

06 Mar
Radiation Oncology

25th Annual International Congress on the Future of Breast Cancer East

Physicians’ Education Resource

10 Jul
Breast Cancer

25th Annual International Congress on the Future of Breast Cancer West

Physicians’ Education Resource

17 Jul
Breast Cancer

10th Annual Live Medical Crossfire: Hematologic Malignancies

Physicians’ Education Resource

11 Jul
Hematologic Malignancies

2026 International Symposium of Gastrointestinal Oncology (ISGIO)

Physicians’ Education Resource

02 Oct
Gastrointestinal Oncology

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The Myth of Lifelong Immunotherapy: Is It Safe to Stop Treatment After Response?

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

OncoDaily TV
60 questions about SCLC with Dr. Greg Kalemkerian Part 2

60 questions about SCLC with Dr. Greg Kalemkerian Part 2

What’s Next for Cancer Care in Armenia? Scott Howard

What’s Next for Cancer Care in Armenia? Scott Howard

The Breast Friends Podcast

Why Hasn’t Immunotherapy Consistently Delivered in HER2+ Disease? – The Breast Friends

Childhood Cancer

Saving One Million Children: WHO’s Global Initiative for Childhood Cancer with Dr. Catherine Lam

Jeffrey Bluestone

Inside the Mind of Jeffrey Bluestone: Lessons From a Lifetime in Immunology

Princess Dina Mired and Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

minister

When Minister is also your treating Doctor – Hosams Abu Meri

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Dr. Navid Madani

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Not To Miss
50th Simeonideios Lecture

15 Posts Not To Miss From 50th Simeonideios Lecture

15 Posts Not To Miss from ESGO 2026

15 Posts Not To Miss From ASCO GU 2026

Top OncoGrants of the Week: Pilot Funding, Team Science, Clinical Trials, and Survivorship Awards (2026)

Top 10 OncoGrants This Week: Horizon Europe €35M Calls, Seed Funding & Venture Competitions (2026)

Oncology This Week: OncoDaily Weekly Feb 16-22, 2026

Oncology This Week: OncoDaily Weekly Feb 9-15, 2026

OncoGrants
American Cancer Society Postdoctoral Fellowship

American Cancer Society Postdoctoral Fellowship

OCRA 2027 Early Career Investigator Grant

OCRA 2027 Early Career Investigator Grant

OCRA 2027 Collaborative Research Development Grant (CRDG)

OCRA 2027 Collaborative Research Development Grant (CRDG)

ASH Scholar Award (2027 Activation Cycle)

ASH Scholar Award (2027 Activation Cycle)

CRUK – Clinical Research Funding Scheme

CRUK – Clinical Research Funding Scheme

CRUK – Discovery Programme Award

CRUK – Discovery Programme Award

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Leandro Jonata de Carvalho Oliveira

Leandro Jonata de Carvalho Oliveira

Oncologists Location São Paulo, Brazil
Rachna Shroff

Rachna Shroff

Oncologists Location Tucson, USA
Zainab Shinkafi-Bagudu

Zainab Shinkafi-Bagudu

Oncologists Location Abuja, Nigeria
Fatma Ben Abid

Fatma Ben Abid

Oncologists Location Rabat, Morocco
Yelena Janjigian

Yelena Janjigian

Oncologists Location New York, USA
Jay M. Lee

Jay M. Lee

Oncologists Location Los Angeles, USA
Melvin L.K. Chua

Melvin L.K. Chua

Oncologists Location Singapore, Singapore
Guillermo Chantada

Guillermo Chantada

Oncologists Location Esplugues de Llobregat, Spain

Oncology Drugs
Lurbinectedin

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

GSK5764227 (HS-20093): Clinical Development of a Next-Generation B7-H3 Directed Antibody–Drug Conjugate

Daraxonrasib (RMC-6236): Clinical Development of a RAS(ON) Inhibitor Advancing Precision Therapy in RAS-Driven Solid Tumors

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma

CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma

AXINET Trial

AXINET (GETNE-1107) Trial : Axitinib Plus Octreotide in Advanced Extrapancreatic NETs

SCREESCO Trial

SCREESCO Trial: Colonoscopy and FIT vs Usual Care in CRC Screening

KRAS G12D Drives Early TNFα-Mediated Niche Programming in Pancreatic Tumorigenesis

KRAS G12D Drives Early TNFα-Mediated Niche Programming in Pancreatic Tumorigenesis

CheckMate 649

CheckMate 649: 5-Year Results of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric, GEJ, and Esophageal Adenocarcinoma

OncoDaily Medical Journal

Precision Oncology

10.69690/ODMJ-002-0226-7267

Unlocking Precision Medicine in Multiple Myeloma: Venetoclax and Novel Targeted Therapies
Review

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6686

Optimizing Quality of Life in Cervical Cancer Survivors: A Comparative Study of Vaginal Doses Delivered Using Three HDR Brachytherapy Applicators
Abstracts